AllianceBernstein
STRO icon

AllianceBernstein’s Sutro Biopharma STRO Stock Holding History

AllianceBernstein’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,637
Closed -$62.7K – 3330
2025
Q1 		$62.7K Hold
9,637
– – ﹤0.01% 3111
2024
Q4 		$177K Hold
9,637
– – ﹤0.01% 3043
2024
Q3 		$333K Hold
9,637
– – ﹤0.01% 2868
2024
Q2 		$282K Buy
9,637
+2,107
+28% +$83.3K ﹤0.01% 2936
2024
Q1 		$425K Hold
7,530
– – ﹤0.01% 2652
2023
Q4 		$323K Hold
7,530
– – ﹤0.01% 2812
2023
Q3 		$261K Buy
7,530
+349
+5% +$15.2K ﹤0.01% 2868
2023
Q2 		$334K Buy
7,181
+2,041
+40% +$102K ﹤0.01% 2821
2023
Q1 		$237K Hold
5,140
– – ﹤0.01% 2859
2022
Q4 		$415K Buy
5,140
+330
+7% +$22.9K ﹤0.01% 2731
2022
Q3 		$267K Buy
4,810
+1,580
+49% +$93.5K ﹤0.01% 2915
2022
Q2 		$168K Sell
3,230
-17,362
-84% -$970K ﹤0.01% 3060
2022
Q1 		$1.69M Sell
20,592
-965
-4% -$91.8K ﹤0.01% 2187
2021
Q4 		$3.21M Buy
21,557
+1,089
+5% +$195K ﹤0.01% 1863
2021
Q3 		$3.87M Buy
20,468
+9,432
+85% +$1.79M ﹤0.01% 1749
2021
Q2 		$2.05M Buy
11,036
+2,154
+24% +$422K ﹤0.01% 2176
2021
Q1 		$2.02M Buy
8,882
+7,292
+459% +$1.73M ﹤0.01% 2097
2020
Q4 		$345K Buy
1,590
+310
+24% +$51.3K ﹤0.01% 2790
2020
Q3 		$129K Hold
1,280
– – ﹤0.01% 3033
2020
Q2 		$99K Buy
+1,280
New +$123K ﹤0.01% 3107

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

AllianceBernstein's STRO Position: Q2 2025 in Review

AllianceBernstein sold out of Sutro Biopharma (STRO) in Q2 2025, closing a stake of 9,637 shares — an estimated $62.7K sold.

AllianceBernstein first reported a position in STRO in Q2 2020 and held it in 20 quarters. The position peaked at $3.87M in Q3 2021. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2025.

  • AllianceBernstein reported no remaining Sutro Biopharma position as of Q2 2025 after selling out during the quarter.
  • AllianceBernstein sold 9,637 Sutro Biopharma shares in Q2 2025, an estimated $62.7K.
  • AllianceBernstein first reported a position in Sutro Biopharma in Q2 2020 and held it in 20 quarters.
  • AllianceBernstein's Sutro Biopharma position peaked at $3.87M in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.